Erikson Pharmaceuticals Private Limited
About Erikson Pharmaceuticals Private Limited
Data last updated:
Erikson Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 05 February 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U14101RJ1996PTC011517. Its GSTIN is 08AACCS5728G1Z9 (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Purushotam Dusad and Renu Dusad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 81 Nehru Nagar, Jaipur, Rajasthan, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹24,246, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹13.75 Lakh and EBITDA of -₹13.6 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 86% over three years and 68% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Erikson Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 81 Nehru Nagar, Jaipur, Rajasthan, India
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Erikson Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Erikson Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Erikson Pharmaceuticals Private Limited, buy the company report.
Financials of Erikson Pharmaceuticals Private Limited
FY 2025 filings availableErikson Pharmaceuticals Private Limited reported revenue of ₹24,246 (down 98% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 68% over five years, including a 98% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹13.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Erikson Pharmaceuticals Private Limited, buy the company report.
Board of directors of Erikson Pharmaceuticals Private Limited
Erikson Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Purushotam Dusad Also directs: Laxmi Jagdish Hotels LLP, Nectar Biochem Private Limited, Maxis Bio Science Private Limited and 2 more | Director | 05 Feb 1996 | 30 Years 8 Months | Current |
| Renu Dusad Also directs: Nectar Biochem Private Limited, Sankalp Finstock Pvt Ltd | Director | 05 Feb 1996 | 30 Years 8 Months | Current |
Auditor
Erikson Pharmaceuticals Private Limited is audited by Akar&Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Akar&Associates | FY 2017 | 006659C |
Shareholding
The shareholding of Erikson Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Erikson Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Erikson Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Erikson Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Erikson Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AACCS5728G1Z9 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Erikson Pharmaceuticals Private Limited, buy the company report.
Recent activity
Erikson Pharmaceuticals Private Limited has 2 board changes on record since 1996: 2 appointments. The latest: Purushotam Dusad was appointed as Director on 05 Feb 1996.
Frequently asked questions
Erikson Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 05 February 1996 (30+ years old) and is registered under CIN U14101RJ1996PTC011517.
Erikson Pharmaceuticals has 2 current directors:
- Purushotam Dusad - Director
- Renu Dusad - Director
The latest financial statements of Erikson Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Erikson Pharmaceuticals is 08AACCS5728G1Z9, registered in Rajasthan.
The CIN (Corporate Identification Number) of Erikson Pharmaceuticals is U14101RJ1996PTC011517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Erikson Pharmaceuticals was incorporated on 05 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Jaipur.
Purushotam Dusad was appointed as Director on 05 Feb 1996. Renu Dusad was appointed as Director on 05 Feb 1996.
The registered office of Erikson Pharmaceuticals is at B – 81 Nehru Nagar, Jaipur, Rajasthan, India.
Erikson Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Erikson Pharmaceuticals is compliant as of 12 August 2026. The company is actively filing with the Registrar of Companies.